Mangoceuticals, Inc.

MGRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$8-$5-$5-$2
Dep. & Amort.$0$1$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1$0
Change in WC-$0$0$0$0
Other Non-Cash$7$3$1-$0
Operating Cash Flow-$1-$1-$2-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$1$0-$0
Stock Issued$2$0$2$1
Stock Repurch.$0$0$0$0
Dividends Paid$0-$1$0-$1
Other Fin. Act.$0$1$0$1
Financing Cash Flow$2$1$2$1
Forex Effect-$0$0$0-$0
Net Chg. in Cash$0$0$0-$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$0$0$0$0
Free Cash Flow-$1-$1-$2-$1
Mangoceuticals, Inc. (MGRX) Financial Statements & Key Stats | AlphaPilot